Worldwide Brain Implant Demand Is Anticipated To Reach US$ 11.1 Billion by 2027

Parenteral Nutrition Market

Brain implants are often referred to as neural implants. Brain implants are categorized as a collection of numerous product types with indications for usage in surgery and health management. Medical devices such as deep brain stimulators and vagus nerve stimulators are among the implants used in the brain.

A nerve cell or neural channel in the nervous system/brain is stimulated through the direct or indirect excitation of its cell membrane by an electric current using a technique known as electrical brain stimulation or electric brain stimulator (EBS), also known as focal brain stimulation. EBS is a type of electrotherapy used in scientific and clinical neurobiology.

To distribute medications to the (CNS) central nervous system, acellular synthetic polymeric brain implants have been made using nanotechnology. The process disperses medication over extended periods, such as months or weeks, by diffusion or degradation.

Patients with Parkinson’s disease can better manage their physical and cognitive functions due to brain implants. In the coming years, it is anticipated that technical developments such as 3-D printing, brain-computer interfaces, and motor neuron prosthesis would help the industry flourish.

Want A Detailed Understanding of Market Functioning? Request for a Sample Here –

What Opportunities in the Brain Implants Market are Attracting New Companies?

“Investments in R&D Activities for Brain Implant Product Development Will Open Opportunities for New Comers”

The market for brain implants is anticipated to see profitable growth prospects as a result of the growing number of research activities that result in technological improvements. These include memory chips and self-charging implants, which are expected to boost market expansion prospects over the projection period.

For instance, the Andersen Lab studies cognitive signals in the Post Parietal Cortex (PPC) for determining the position of the intended target during motion. The signals that the cortex receives are used to control the equipment.

  • Furthermore, over the projection period, market expansion is anticipated to be aided by the possible advantages of these devices, such as improved postoperative outcomes management and long-term efficacy. It is projected that these important reasons would increase the sales of brain implants.
  • A new start-up of Elon Musk’s odd and futuristic businesses is Neuralink. It is creating technology for neural interfaces, also known as implanting microchips in human brains. Neurological problems can be studied and treated with the aid of neuralink brain implant technology.
  • The chip aims to enable those with severe paralysis to interact or communicate by thinking. Similar goals are provided by Elon Musk’s neuralink implant machine, which is still waiting for FDA approval.

Elon Musk recently declared that the business hoped to begin incorporating its microchip into the human (brain) by 2022. The billionaire and co-founder uploaded a video just before making the announcement, of a monkey utilizing a Neuralink brain chip to play a video game using its mind.

What Makes the United States a Profitable Market for Neural Implant Suppliers?

“Effective Results of Neural Implant Treatment Due to Qualified Doctors & Growing Cases of Alzheimer’s Disease”

Market for brain implants in the United States is expected to expand quickly. This is due to several factors, such as an increase in the prevalence of neurological illnesses, high public awareness of available treatments, well-developed healthcare infrastructure, and the presence of morally upright doctors.

According to medical experts, brain implants are the most effective kind of treatment for depression in the country.

  • The number of new and active cases of Alzheimer’s disease will rise along with the number of senior persons in the United States, predicts the statistics provided by Alzheimer’s Disease Facts and Figures.
  • The number of people aged 65 and older with Alzheimer’s disease is predicted to increase to 12.7 million by 2050 if medical advancements to prevent, treat, or cure the disease are not made.

Why are Deep Brain Stimulators Widely Demanded?

“Preferred Use of Deep Brain Stimulators in Treating Several Neurological Diseases”

Sales of deep brain stimulators are expected to expand at a CAGR of 11% from 2022 to 2027.

Technological developments such as rechargeable implantable pulse generators, robot-assisted implantation, and an increase in the use of advanced deep brain stimulator systems in hospitals and neuro centres are major factors for this surge.

Due to the increasing prevalence of Parkinson’s disease, it is projected that the product will continue to hold the top spot during the forecast period. One of the main factors influencing the growth of this market is the increasing use of DBS for the treatment of several neurological illnesses, such as obsessive-compulsive disorder (OCD), dystonia, epilepsy, essential tremor, and Alzheimer’s disease.

Speak To Research Analyst For Detailed Insights:

Competitive Landscape

Market participants are consistently expanding their product offerings and creating better analytical solutions. Alliances, technological partnerships, and product launch strategies of the businesses in the market for brain implants are their main priorities.

Medtronic plc, in June 2021, announced that SenSight Directional Lead System, which is utilized for deep brain stimulation therapy, received FDA approval.

Key Market Players:

  • Medtronic Plc
  • Boston Scientific Corporation
  • St Jude Medical, Inc (Abbott)
  • Synapse Biomedical Inc
  • Nevro Corporation
  • NDI Medical LLC
  • Terumo Corporation
  • Edwards Lifesciences Corporation
  • NeuroPace, Inc
  • LivaNova PLC
  • Synchron Inc
  • Functional Neuromodulation Ltd
  • Beijing PINS Medical Co Ltd
  • Renishaw Plc
  • Aleva Neurotherapeutics SA

Key Segments in Brain Implants Industry Research

By Product :

  • Deep Brain Stimulators
  • Spinal Cord Stimulators
  • Vagus Nerve Stimulators

By Application :

  • Chronic Pain
  • Epilepsy
  • Parkinson’s disease
  • Depression
  • Essential Tremor
  • Alzheimer’s Disease
  • Obsessive-compulsive Disorder
  • Multiple Sclerosis
  • Dementia

By End User :

  • Hospitals
  • Neurological Centers
  • Specialized Clinics
  • Others

By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA

Choose Quick and Secure PayPal Payment Mode to Get Full Access of This Report

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Visit Our Website:


Leave a Reply

Your email address will not be published. Required fields are marked *